Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
about
Localized Delivery of shRNA against PHD2 Protects the Heart from Acute Myocardial Infarction through Ultrasound-Targeted Cationic Microbubble Destruction.Pretreatment with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-D-pyranoside attenuates cerebral ischemia/reperfusion-induced injury in vitro and in vivo.Coronary angiogenic effect of long-term administration of Nigella sativa.Effect of BMAP-28 on human thyroid cancer TT cells is mediated by inducing apoptosis.Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectorisInhibiting the effect of (90)Sr-(90)Y ophthalmic applicators on rat corneal neovascularization induced by sutures.Erythropoietin protects the tubular basement membrane by promoting the bone marrow to release extracellular vesicles containing tPA-targeting miR-144.High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy.Erythropoietin and Its Angiogenic Activity.Erythropoietin enhances Kupffer cell number and activity in the challenged liver.EPO modified MSCs can inhibit asthmatic airway remodeling in an animal model.Erythropoietin Attenuates Cardiac Dysfunction in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Diabetic Cardiomyopathy.TT-1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl-2 and Bax.Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".Regulation of TLR4 expression mediates the attenuating effect of erythropoietin on inflammation and myocardial fibrosis in rat heart.
P2860
Q30367062-15CBE8A1-462E-452A-8F1A-AF04B696704DQ31171872-7E9FBB9F-C118-4506-ACA4-282D186CF22BQ33796127-5C9E0052-6BA3-49EC-9FF5-BBE5D804E4F8Q36085953-8A071B16-7EB3-4DE2-A659-7BC209190479Q36687489-A91299A9-FBEC-40FF-BBE0-6FE341C63BB6Q37266865-42C95334-18D5-4A30-95B9-86EFB74B9684Q38827683-95B7148F-3CCC-4D43-8B26-CB1B059A82BEQ38989355-39179DD6-C42F-4C4D-A1FB-BA1ADE7E879AQ39432541-5FC21904-BB47-43E5-A057-7EDF7C789F73Q41606522-1F7C35A1-1232-4A5E-B922-6B45F4B8E001Q47840335-10F762B2-CFE0-47A4-9EB5-17CD89A17E4AQ47988307-91963B80-F9F5-4C83-AB4C-385D7F7AFB64Q49181747-E5858743-EBE5-4101-9C77-3FB923B52CA8Q49203906-10E912AF-33A2-4DCA-8231-5E43B60126C1Q54977728-504371FF-1F29-493F-B462-D127983F764F
P2860
Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Erythropoietin attenuates card ...... ial fibrosis in diabetic rats.
@en
type
label
Erythropoietin attenuates card ...... ial fibrosis in diabetic rats.
@en
prefLabel
Erythropoietin attenuates card ...... ial fibrosis in diabetic rats.
@en
P2093
P2860
P356
P1476
Erythropoietin attenuates card ...... ial fibrosis in diabetic rats.
@en
P2093
Gen-shan Ma
Li-qun Ren
Nai-feng Liu
Qi-ming Dai
Shu-feng Zhang
P2860
P2888
P356
10.1186/1475-2840-11-105
P407
P577
2012-09-07T00:00:00Z
P5875
P6179
1034621822